SCHEMBL7400239

SCHEMBL7400239

Cc1nsc(-c2ccccc2N)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 6/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
NPC1 O15118 5/20 0.47
GAA P10253 4/20 0.47
RAB9A P51151 4/20 0.47
MAPT P10636 4/20 0.47
TDP1 Q9NUW8 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 2/20 0.42
PPARG P37231 1/20 0.42
NCOA2 Q15596 1/20 0.42
NCOA1 Q15788 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
ADORA2A P29274 2/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2B P29275 1/20 0.40
ADORA1 P30542 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14420398 0.82 ALDH1A1 (0.41) ALDH1A1KDM4ESMN1; SMN2NPC1GAA
SCHEMBL31533451 0.79 HTR2B (0.47) ALDH1A1KDM4ESMN1; SMN2NPC1GAA
SCHEMBL7397370 0.71 KDM4E (0.49) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL829862 0.71 PDE10A (0.53) ALDH1A1KDM4ESMN1; SMN2NPC1GAA
SCHEMBL31158160 0.69 ALDH1A1 (0.55) ALDH1A1KDM4ESMN1; SMN2NPC1GAA
SCHEMBL6226821 0.69 ALDH1A1 (0.56) ALDH1A1KDM4ESMN1; SMN2NPC1GAA
SCHEMBL30955289 0.69 ALDH1A1 (0.53) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL30955225 0.69 RAB9A (0.52) ALDH1A1KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL31121977 0.68 GAA (0.46) ALDH1A1KDM4ESMN1; SMN2NPC1GAA
SCHEMBL17845444 0.68 GAA (0.46) ALDH1A1KDM4ESMN1; SMN2NPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0972773-A1 2-Oxadiazolyl- or 2-thiadiazolyl-phenylcarbamate and -phenylurea derivatives, their preparation and their use as intermediates GLAXO GROUP LIMITED (GB) 2000-01-19 EP disclosed
EP-0640081-B1 SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT4 ANTAGONISTS GLAXO GROUP LTD (GB) 2000-01-12 EP disclosed
US-5618827-A TREATING GASTROINTESTINAL, URINARY, CARDIOVASCULAR, CENTRAL NERVOUS SYTEM DISORDERS GLAXO GROUP LIMITED (GB) 1997-04-08 US disclosed
EP-0640081-A1 SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS GLAXO GROUP LIMITED (GB) 1995-03-01 EP disclosed
WO-1993020071-A1 SUBSTITUTED PHENYLCARBAMATES AND PHENYLUREAS, THEIR PREPARATION AND THEIR USE AS 5-HT ANTAGONISTS GLAXO GROUP LIMITED (GB) 1993-10-14 WO disclosed